Department of Innovative Research & Education for Clinicians & Trainees (DiRECT)

英文原著 2017年度実績

  1. Omae K, Tsujimoto Y, Honda M, Kondo T, Tanabe K, Fukuhara S, Furukawa T.
    Comparative Efficacy and Safety of Bone-modifying Agents for the Treatment of Bone Metastases in Patients with Advanced Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
    Oncotarget  2017 18; 8: 68890-68898.
    [紹介記事]
  2. Yokoyama K*, Kurita N*, Fukuma S, Akizawa T, Fukagawa M, Onishi Y, Kurokawa K, Fukuhara S. (*co-first authors)
    Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy.
    Nephrology Dialysis Transplantation 2017; 32: 534-541.
    [abstract][紹介記事][海外学会の公表記事]
  3. Kurita N, Hayashino Y, Yamazaki S, Akizawa T, Akiba T, Saito A, Fukuhara S.
    Revisiting Interdialytic Weight Gain and Mortality Association With Serum Albumin Interactions: The Japanese Dialysis Outcomes and Practice Pattern Study.
    Journal of Renal Nutrition 2017; 27: 421-429.
    [abstract][紹介記事]
  4. Omae K, Fukuma S, Ikenoue T, Kondo T, Takagi T, Ishihara H, Tanabe K, Fukuhara S
    Effect of ABO blood type on the outcomes of patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors.
    Urologic Oncology 2017; 35: 540.e7-540.e12. 
  5. Miyamoto M, Kurita N, Suemitsu K, Murakami M.
    Fistula and survival outcomes after fistula creation among predialysis chronic kidney disease stage 5 patients.
    American Journal of Nephrology 2017; 45: 356-364.
    [abstract][紹介記事][Editorial記事]
  6. Omae K, Kondo T, Takagi T, Iizuka J, Hashimoto Y, Kobayashi H, Tanabe K.
    Surgical and Oncologic Outcomes of Laparoscopic Radical Nephrectomy for Non-metastatic Renal Cancer in Long-term Dialysis Patients.
    Ther Apher Dial. 2017; 21: 31-37.
  7. Kataoka Y, Yamamoto S, Omae K, Kokubo M, Goto Y, Takada T, Naganuma T, Nishiwaki H, Yajima N.
    A novel approach of understanding prediction models: TRIPOD framework.
    Journal of General and Family Medicine 2017; 18: 319-320.
  8. Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K.
    Evaluation of preoperative aspartate transaminase/alanine transaminase ratio as an independent predictive biomarker in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy: A propensity score matching study.
    Clinical Genitourinary Cancer 2017; 15: 598-604.
  9. Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K.
    Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy.
    Urologic Oncology 2017; 35: 539.e9-539.e16.
  10. Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K.
    Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapy.
    Urologic Oncology 2017; 35: 542.e1-542.e9.
  11. Ishihara H, Kondo T, Fukuda H, Yoshida K, Omae K, Takagi T, Iizuka J, Kobayashi H, Tanabe K.
    Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.
    Jpn J Clin Oncol 2017; 47(12): 1175-1181.
  12. Kobari Y, Kondo T, Takagi T, Omae K, Nakazawa H, Tanabe K.
    Rapid Progressive Disease After Nivolumab Therapy in Three Patients with Metastatic Renal Cell Carcinoma.
    In Vivo 2017; 31(4): 769-771.
  13. Takagi T, Kondo T, Tachibana H, Iizuka J, Omae K, Yoshida K, Kobayashi H, Okumi M, Ishida H, Tanabe K.
    Comparison of Surgical Outcomes Between Resection and Enucleation in Robot-Assisted Laparoscopic Partial Nephrectomy for Renal Tumors According to the Surface-Intermediate-Base Margin Score: A Propensity Score-Matched Study.
    J Endourol 2017; 31(8): 756-761.
  14. Takagi T, Kondo T, Tachibana H, Iizuka J, Omae K, Kobayashi H, Yoshida K, Tanabe K.
    Robot-assisted laparoscopic versus open partial nephrectomy in patients with chronic kidney disease: A propensity score-matched comparative analysis of surgical outcomes.
    Int J Urol 2017; 24(7): 505-510.
  15. Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K.
    Effect of Systemic Inflammation on Survival in Patients With Metastatic Renal Cell Carcinoma Receiving Second-line Molecular-targeted Therapy.
    Clin Genitourin Cancer 2017; 15(4): 495-501.
  16. Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Kobayashi H, Tanabe K.
    Evaluation of tumor burden after sequential molecular-targeted therapy in patients with metastatic renal cell carcinoma.
    Jpn J Clin Oncol 2017; 47(3): 226-232.
  17. Ishihara H, Yagisawa T, Kondo T, Omae K, Takagi T, Iizuka J, Kobayashi H, Tanabe K.
    Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy.
    Int J Clin Oncol 2017; 22(1): 126-135.
  18. Kondo T, Hara I, Takagi T, Kodama Y, Hashimoto Y, Kobayashi H, Iizuka J, Omae K, Yoshida K, Tanabe K.
    Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer.
    Int J Clin Oncol 2017; 22(1): 145-152.
  19. Ishihara H, Kondo T, Omae K, Takagi T, Iizuka J, Kobayashi H, Hashimoto Y, Tanabe K.
    Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study.
    Int J Clin Oncol 2017; 22(1): 136-144.

研究実績

PAGETOP